Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.
MJH Life Sciences™ is offering a free webinar covering potential vaccines for the novel coronavirus disease 2019 (COVID-19) on July 30 at 6 p.m. Eastern Daylight Time (EST).
As the death toll of the COVID-19 coronavirus pandemic rises above 136,000 Americans and more than 4 million Americans have tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, the country awaits the development of a vaccine and the end of the COVID-19 pandemic.
With the advancing development of a vaccine, and with legislation already being passed allowing pharmacists to administer a COVID-19 vaccine, the United States’ most accessible health care professionals must remain preparedand informed on budding phase 3 trials and leading research. The webinar will also discuss how to combat logistical challenges associated with rolling out a vaccine in the middle of a pandemic.
The 1-hour webinar will confront the race for a vaccine and feature experts on viruses and vaccines who will delve into the research at the forefront of COVID-19 vaccine development.
Click here to register for the free event
The panel for this webinar features: